Schedule 13G ownership disclosure
Corium International, Inc.
Security class unavailable · CUSIP: 21887L107
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,875,000
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001095449-18-000015
- Form type
- SC 13G
- Filer
- Correvio Pharma Corp.
- CIK
- CIK 1036141
- Filed
- Feb 14, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership